Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 5:45 pm Unchanged | 2024-11-04 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,483,196 11.400% | 0 (Unchanged) | Filing History |
| 2024-10-24 08:57 am Sale | 2024-10-22 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,483,196 11.800% | -423,180 (-2.24%) | Filing History |
| 2024-06-24 7:56 pm Sale | 2024-06-21 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,906,376 12.300% | -50,000 (-0.26%) | Filing History |
| 2024-05-17 9:37 pm Unchanged | 2024-05-16 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,956,376 12.900% | 0 (Unchanged) | Filing History |
| 2024-04-08 5:44 pm Unchanged | 2024-04-04 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,956,376 13.100% | 0 (Unchanged) | Filing History |
| 2024-02-22 4:17 pm Purchase | 2024-02-13 | 13G | Renovaro Biosciences Inc. RENB | Abildgaard Ole | 11,162,447 7.600% | 1,000,000 (+9.84%) | Filing History |
| 2024-02-16 6:11 pm Unchanged | 2024-02-14 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,956,376 13.200% | 0 (Unchanged) | Filing History |
| 2024-02-16 3:03 pm Purchase | 2024-02-13 | 13D | Renovaro Biosciences Inc. RENB | Sindlev Rene | 14,945,971 10.280% | 14,945,971 (New Position) | Filing History |
| 2024-01-24 4:08 pm Purchase | 2023-08-01 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 14,945,971 20.900% | 1,084,500 (+7.82%) | Filing History |
| 2024-01-24 4:08 pm Purchase | 2023-06-26 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 13,861,471 23.300% | 2,830,191 (+25.66%) | Filing History |
| 2024-01-24 4:07 pm Purchase | 2023-03-17 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 11,031,280 19.600% | 1,328,472 (+13.69%) | Filing History |
| 2024-01-24 4:07 pm Purchase | 2021-09-24 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,702,808 18.600% | 17,557 (+0.18%) | Filing History |
| 2024-01-24 4:06 pm Purchase | 2019-09-30 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,685,251 20.900% | 170,114 (+1.79%) | Filing History |
| 2024-01-24 4:05 pm Purchase | 2018-12-27 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,515,137 24.200% | 94,268 (+1.00%) | Filing History |
| 2024-01-24 4:05 pm Unchanged | 2018-02-16 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,420,869 23.200% | 0 (Unchanged) | Filing History |
| 2024-01-24 4:04 pm Purchase | 2017-10-13 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,420,869 48.600% | 250,000 (+2.73%) | Filing History |
| 2024-01-24 4:04 pm Purchase | 2017-04-21 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 9,170,869 51.400% | 8,100,000 (+756.40%) | Filing History |
| 2024-01-24 4:03 pm Purchase | 2016-03-14 | 13D | DANDRIT BIOTECH USA DDRT | Sindlev Rene | 1,070,869 11.200% | 1,070,869 (New Position) | Filing History |
| 2023-11-03 5:25 pm Purchase | 2023-10-27 | 13D | Renovaro Biosciences Inc. RENB | William Anderson Wittekind | 18,956,376 28.400% | 1,411,093 (+8.04%) | Filing History |
| 2023-10-06 4:34 pm Purchase | 2023-08-01 | 13G | Renovaro Biosciences Inc. RENB | Abildgaard Ole | 10,162,447 13.900% | 5,154,285 (+102.92%) | Filing History |